-
Uncategorized2 weeks ago
Wainua flop narrows AstraZeneca’s path to $80B goal ahead of high-risk readouts
With a Phase 3 failure denting the rare disease drug’s prospects, AstraZeneca has little room for error as it plots a path toward its ambitious 2030...
-
Uncategorized2 weeks agoUCSD, IGI Partnership Expands CRISPR Innovation Across Health, Agriculture, and the Environment
UCSD, IGI Partnership Expands CRISPR Innovation Across Health, Agriculture, and the Environment
-
Uncategorized2 weeks ago
A spatial view of tumor neoantigen recognition
Nature Biotechnology, Published online: 22 July 2026; doi:10.1038/s41587-026-03203-3 The cell-by-cell interactions between neoantigen-expressing tumor cells and tumor-specific T cells remained largely unexplored. A single-cell spatial transcriptomics...
-
Uncategorized2 weeks agoTrump administration says it’s deferring $1B in Medicaid payments to California and Minnesota
The Trump administration on Tuesday said it was deferring more than $1 billion in Medicaid payments to Minnesota and California because of “suspected fraud and noncompliance,”...
-
Uncategorized2 weeks agoSTAT+: Rare disease drugmakers try to avoid Trump price cuts
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your...
-
Uncategorized2 weeks ago
Samsung Biologics targets $1.8B PolyPeptide buyout to expand in obesity
With PolyPeptide manufacturing peptides such as GLP-1 medicines, Samsung Biologics has identified the deal as a way to tap into fast-growing demand for obesity drug production...
-
Uncategorized2 weeks ago10x Clinical Expansion Advances with CLIA Lab Plans, Cleveland Clinic Partnership
10x Genomics says it is on track to build out a CLIA-certified laboratory set to open next year, part of the spatial and single-cell tools developer’s...
-
Uncategorized2 weeks ago
Blood Cancer Therapies Informed by Spatial Remodeling of Bone Marrow
Blood Cancer Therapies Informed by Spatial Remodeling of Bone Marrow
-
Uncategorized2 weeks agoAgios scraps sickle cell drug
The study failure costs Agios a chance to one-up Novo Nordisk and represents yet another setback in a disease that’s frustrated drugmakers of late.
-
Uncategorized2 weeks agoOpinion: Pete Hegseth, ‘The Odyssey,’ and the testosterone myth
The past week has brought us two similar ideas of masculinity, separated by 4,000 years. When Defense Secretary Pete Hegseth announced the initiation of testosterone screening...
